Agenus (AGEN) Accumulated Depreciation (2014 - 2025)
Agenus (AGEN) posted quarterly Accumulated Depreciation of $47.5 million for Q4 2025, down 34.57% year-over-year from $72.6 million in Q4 2024, and down 34.57% quarter-over-quarter from $72.6 million in Q4 2024.
Analysis
Agenus (AGEN) Accumulated Depreciation (2014 - 2025) Analysis & Trends
Agenus' Accumulated Depreciation history runs 12 years deep, the most recent figure standing at $47.5 million for Q4 2025.
- In Q4 2025, Accumulated Depreciation fell 34.57% year-over-year to $47.5 million; the TTM figure through Dec 2025 stood at $47.5 million (down 34.57% YoY), while the FY2025 annual figure was $47.5 million, down 34.57% from the prior year.
- Accumulated Depreciation for Q4 2025 stood at $47.5 million, down from $72.6 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $72.6 million in Q4 2024, with the low at $47.5 million in Q4 2025.
- The 5-year median for Accumulated Depreciation is $54.1 million (2022), against an average of $57.3 million.
- The sharpest annual moves came in 2024 and 2025: Accumulated Depreciation increased 17.13% in 2024, then tumbled 34.57% in 2025.
- Agenus' Accumulated Depreciation stood at $50.5 million in 2021, then grew by 7.0% to $54.1 million in 2022, then rose by 14.55% to $61.9 million in 2023, then increased by 17.13% to $72.6 million in 2024, then sank by 34.57% to $47.5 million in 2025.
- Business Quant data shows AGEN's Accumulated Depreciation at $47.5 million in Q4 2025, $72.6 million in Q4 2024, and $61.9 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Agenus | 342.07 Mn | 342.07 Mn | 34.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 47.47 Mn |
| Dec 31, 2024 | 72.55 Mn |
| Dec 31, 2023 | 61.94 Mn |
| Dec 31, 2022 | 54.08 Mn |
| Dec 31, 2021 | 50.54 Mn |
| Dec 31, 2020 | 47.20 Mn |
| Dec 31, 2019 | 42.86 Mn |
| Dec 31, 2018 | 38.07 Mn |
| Dec 31, 2017 | 34.03 Mn |
| Dec 31, 2016 | 31.24 Mn |
| Dec 31, 2015 | 29.49 Mn |
| Dec 31, 2014 | 28.37 Mn |